Researchers report on the early development of anti-HIV neutralising antibodies

New findings are bringing scientists closer to an effective HIV vaccine. Researchers from Seattle Biomedical Research Institute (Seattle BioMed), Vanderbilt University and the Ragon Institute of MGH, MIT and Harvard report findings showing new evidence about broadly-reactive neutralising antibodies, which block HIV infection. Details are published January 13 in the open-access journal PLoS Pathogens...

Read the whole article on

More from